XAV-19 a Glyco-Humanized polyclonal antibody targeting SARS-CoV-2 accelerates the recovery of mild to moderate COVID-19 patients and keeps its neutralizing activity against Omicron and its subvariants
Poulakou et al., medRxiv, doi:10.1101/2023.10.09.23296726
https://c19early.org/poulakou.html